These novel treatments, Tirzepatide , represent a groundbreaking advancement in managing metabolic dysfunction and potentially associated disorders. These drugs are categorized as GLP-1 pathway activators , signifying they function to emulate the endogenous GLP-1 hormone , enhancing glucose produ